Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 95 The United Laboratories International Holdings Limited Annual Report 2021 10. DISPOSAL OF A SUBSIDIARY (Continued) 31/12/2021 31/12/2020 Net Net Undiscounted carrying Undiscounted carrying amount amount amount amount RMB’000 RMB’000 RMB’000 RMB’000 Consideration receivables: Cash consideration receivables within 12 months 343,000 – 171,500 158,000 Cash consideration receivables after 12 months – – 171,500 105,679 Total cash consideration receivables (Note) 343,000 – 343,000 263,679 Note: The consideration receivables are measured at fair value at the date of disposal, based on the present value of the estimated future cash flow discounted using the effective interest rate of 12% per annum and carried at amortised cost subsequently. The effective interest rates were determined by the directors of the Company by reference to a valuation performed by WeValue Advisory Limited. WeValue Advisory Limited is an independent qualified professional valuer which is not connected with the Group.